Holbaek, Denmark

Erik Skibsted

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Novo Nordisk A/s. Active years: 2018-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erik Skibsted. Retrieved from https://idiyas.com/inventor/erik-skibsted

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Erik Skibsted - Innovator from Hollbaek, Denmark

Introduction: Erik Skibsted is a renowned inventor hailing from Hollbaek, Denmark, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: Erik Skibsted holds several patents in the areas of sustainable energy solutions, urban mobility, and eco-friendly technologies, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a background in engineering and a passion for problem-solving, Erik Skibsted has successfully brought to life numerous inventions that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Erik Skibsted has collaborated with leading research institutions, universities, and innovative companies to further develop his ideas and bring them to the market successfully.

Conclusion: Erik Skibsted's dedication to innovation and sustainable solutions has solidified his position as a respected inventor in the global innovation landscape, with his work continuing to inspire future generations of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…